Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025

65 companies Today

Tencent Holdings Limited

0700.HK Q1 2026

Reported: 2026-05-14

Tencent's shares gained modestly by 1.2% after reporting a 9% revenue increase (11% adjusted for calendar effects) and steady gross profit growth, reflecting a largely in-line quarter with ongoing AI investments and product traction but no clear upside to materially surprise investors.

Key takeaways

Total revenue reached RMB 196 billion, up 9% year-on-year, or 11% adjusted for later Spring Festival revenue timing which shifted some game-related revenue forward.
Gross profit increased 11% to RMB 111 billion, supported by solid performance across VAS, Marketing Services, and FinTech segments.
Non-IFRS operating profit was RMB 76 billion, up 9%, with a stronger 17% rise excluding the impact of new AI product investments.
Communication and social networks MAU reached 1.4 billion, increasing both year-over-year and sequentially.
The upgraded Hunyuan large language model is making early progress, with broad internal deployment and leading usage metrics in China, though still viewed as early-stage from a commercialization perspective.

Alibaba Group Holding Limited

9988.HK Q4 2026

Reported: 2026-05-14

Alibaba’s shares gained 3.5% following the quarter, driven by faster-than-expected revenue growth in its AI + Cloud businesses and accelerating margin improvements. The cloud segment posted a 40% revenue increase, with AI-related product revenue growing triple digits and becoming a larger share of total cloud revenue.

Key takeaways

Cloud Intelligence Group external revenue grew 40% year-over-year, accelerating from prior quarters.
AI-related product revenue in cloud now accounts for 30% of external revenue, surpassing RMB 35.8 billion annualized, with triple-digit growth sustained for 11 consecutive quarters.
Model and application services ARR expected to exceed RMB 10 billion in the coming quarter and RMB 30 billion by year-end, highlighting expansion of high-margin revenue streams.
China e-commerce CMR (consumer marketing revenue) grew 8% year-over-year on a like-for-like basis, showing recovery in core consumption business.
Significant unit economics improvements reported in the quick commerce segment while maintaining market share, aiding overall operating efficiency.

ABN AMRO Bank N.V.

ABN.AS Q1 2026

Reported: 2026-05-14

The stock surged 12.5% as ABN AMRO delivered notable beats in fee income and commercial net interest income, underpinned by record-high clearing fees and solid deposit growth, while also lowering full-year cost guidance.

Key takeaways

Net profit increased 12% year-over-year to EUR 693 million, driving a return on equity of 10.7%.
Commercial net interest income rose by EUR 36 million, supported primarily by growing deposit volumes despite a slight margin contraction on mortgages from a larger share of government-backed loans.
Fee income climbed 6% quarter-on-quarter, driven by new client account pricing and robust trading activity amid high market volatility, especially in clearing and global markets.
Costs are coming down faster than expected, prompting a lowered full-year cost guidance to approximately EUR 5.5 billion, with EUR 60 million saved in Q1 alone.
Credit quality remains stable with a low cost of risk at 9 basis points despite geopolitical uncertainties; capital remains strong with a CET1 ratio of 15.5%.

Alfen N.V.

ALFEN.AS Q1 2026

Reported: 2026-05-14

Alfen’s Q1 results were well-received with the stock rallying 14.7%, driven primarily by better-than-expected revenue growth in Energy Storage and Smart Grids, as well as margin improvements, despite a notable decline in EV Charging revenue.

Key takeaways

Total revenue increased 25% YoY to EUR 129.7 million, mainly fueled by Energy Storage and Smart Grid project expansion.
Adjusted gross margin improved in absolute terms (EUR 34 million vs EUR 31 million), though margin percentage declined due to a business mix shift toward Energy Storage Systems.
Smart Grid Solutions revenue grew 2.7% to EUR 55.8 million, supported by increased production of substations (833 units), with gross margin expanding to 25.2% from 23.9%.
EV Charging revenue declined 19% to EUR 23.3 million, reflecting product portfolio renewal, with unit deliveries falling 12% to approximately 25,000 charge points; margin held steady at 39.9%.
Alfen reiterated its 2026 guidance and emphasized progress on transformation initiatives, including customer-centric restructuring and enhanced digital platforms for EV charging.

Altius Minerals Corporation

ALS.TO Q1 2026

Reported: 2026-05-14

Altius shares declined modestly by 1.0% following Q1 results, reflecting investor caution despite higher revenues and adjusted EBITDA, driven largely by one-time expenses and ongoing early-stage challenges in key segments like lithium.

Key takeaways

Q1 net earnings were $2.6 million ($0.05/share), impacted by higher expenses including nonrecurring post-closing fees related to the Lithium Royalty Corp (LRC) acquisition.
Royalty revenue rose to $27 million, supported by higher realized prices, timing of copper stream deliveries, increased electricity royalties, and the addition of four lithium royalties.
Adjusted EBITDA reached $20 million, while adjusted net earnings improved to $0.11 per share compared to the prior year.
Operating cash flow was pressured by increased tax payments, working capital shifts, and the LRC-related costs.
The electricity royalties business (Altius Renewable Royalties/Great Bay Royalties) shows potential with accelerating revenue and a robust pipeline; however, competition and investment timing remain challenges.

Altimmune, Inc.

ALT Q1 2026

Reported: 2026-05-14

Altimmune's shares declined 1.9% following Q1 results as the market digested ongoing progress on pipeline development but showed caution given the lack of new catalytic data and the company’s still-early clinical stage profile.

Key takeaways

Completed an oversubscribed $225 million public offering in April, bringing cash balance to approximately $535 million, securing funding through Phase III MASH 52-week readout expected in 2027.
Preparing to initiate global Phase III PERFORMA study for pemvidutide in MASH in H2 2026, with finalized protocol aligned with FDA and EMA feedback.
Anticipated top-line data from Phase II AUD trial next quarter; enrollment in ALD RESTORE trial expected to complete in Q3 2026.
No new clinical efficacy or safety data disclosed this quarter; update primarily focused on trial preparations, regulatory alignment, and financing.
Market reaction suggests investors remain cautious, reflecting execution risk and absence of near-term catalysts beyond trial initiation.

Allianz SE

ALV.DE Q1 2026

Reported: 2026-05-14

The stock gained 3.3% following a solid quarter marked by better-than-expected growth and profitability, driven by record operating profit in P&C and strong results in Asset Management. The market rewarded the company’s resilience and execution despite ongoing macroeconomic uncertainty.

Key takeaways

Operating profit rose nearly 7% year-on-year, led by a double-digit increase in P&C reaching a new record level and a 6% (15% FX-adjusted) rise in Asset Management profits.
P&C volume grew internally by 7%, split evenly between price and volume, with a combined ratio of 91%, reflecting strong underwriting profitability and improved expense management.
Life & Health business showed resilience; new business volumes were slightly up when adjusting for prior-year high comparables, FX, and disposals, with attractive product mix and normalized Life CSM growth of 1.7%.
Core net income, excluding the one-time EUR 1.1 billion Bajaj disposal gain, rose 7%, with return on equity at 18% and EPS growth of 9%, indicating solid underlying earnings momentum.
The Solvency II ratio remained strong at 221%, evidencing robust capital generation and risk resilience amid market volatility.

Avon Rubber p.l.c.

AVON.L Q2 2026

Reported: 2026-05-14

Shares declined 5.4% following the report, primarily driven by weaker-than-expected order intake, production delays in Team Wendy, and a cautious midyear outlook despite robust margin expansion and profit growth.

Key takeaways

Order intake declined, with Team Wendy particularly impacted by delayed production ramp-up and soft commercial orders affected by grant funding delays.
Revenue grew 6.8% overall, led by Avon Protection's 23% increase driven by military and commercial demand as well as Ukraine-related orders.
Adjusted operating profit rose 39%, with margins expanding over 300 basis points to 15.2%, helped by product mix and operational gearing mainly in Avon Protection.
Cash conversion was weak at 38%, primarily due to working capital increases and timing of cash receipts, though adjusted for early April receipts conversion would have been near 100%.
While the outlook notes modest sequential growth in H2, visibility remains limited with signs of recovery offset by slower production and spending timing, contributing to investor caution.

Alibaba Group Holding Limited

BABA Q4 2026

Reported: 2026-05-14

Alibaba’s shares rose 8.2% after the quarter, reflecting accelerating Cloud Intelligence Group revenue growth, notably a 40% increase, and sustained triple-digit growth in AI-related product revenue that now accounts for 30% of cloud revenue.

Key takeaways

Cloud Intelligence Group external revenue grew 40% year-over-year, driven by AI commercialization.
AI-related product revenue surpassed RMB 35.8 billion annualized, maintaining triple-digit growth for the 11th consecutive quarter.
AI-related products represent 30% of Cloud Intelligence Group’s revenue, with expectations to exceed 50% within a year.
China e-commerce CMR grew 8% on a like-for-like basis, showing steady consumption business momentum.
Quick commerce unit economics improved significantly while maintaining stable market share.

Bain Capital Specialty Finance, Inc.

BCSF Q1 2026

Reported: 2026-05-14

Bain Capital Specialty Finance’s shares were little changed (+0.9%) following Q1 results, reflecting an earnings quarter marked by net unrealized losses offset by stable credit fundamentals and a cautious outlook amid broader market volatility.

Key takeaways

Net investment income per share was $0.42, covering the regular dividend and implying a 10.0% annualized return on equity.
Q1 GAAP EPS was $0.05, impacted primarily by net unrealized losses attributed to idiosyncratic credit weakness and credit spread widening.
Nonaccrual loans remained low and stable with no new shifts to nonaccrual, signaling continued portfolio credit resilience.
New investments slowed due to risk aversion linked to market volatility, inflation concerns, and AI-related disruption risks, particularly in software exposures (~13% of the portfolio).
Pricing on new originations averaged ~550 basis points with prudent leverage at 4.4x EBITDA; Q2 has seen a pickup in investment volume amid modestly wider spreads.

Bionano Genomics, Inc.

BNGO Q1 2026

Reported: 2026-05-14

Bionano’s shares fell 0.8% after earnings, reflecting investor caution despite modest growth in consumable revenues and improved reimbursement codes; softness in software revenue and ongoing execution risks likely weighed on sentiment.

Key takeaways

Q1 2026 flow cell sales reached a record 8,178 units, up 17% year-over-year, with flow cells sold to existing customers up 21% YoY.
Consumable revenue grew 20% year-over-year to $3.9 million, signaling traction in routine users and OGM focus.
Software revenue declined sharply by 40% year-over-year to $1.2 million due to a large prior-year sale that supplied customers through 2026.
Other revenue increased 36% year-over-year to $1.6 million, reflecting a higher proportion of recurring revenues.
Two significant reimbursement milestones took effect, increasing payment rates for key CPT codes by up to 47%, potentially improving long-term adoption economics.

Brightstar Lottery

BRSL Q1 2026

Reported: 2026-05-14

Shares plunged 14.1% following the earnings release, reflecting investor disappointment with soft same-store sales in the U.S. market and cautious commentary around growth sustainability despite margin improvements and underlying revenue gains.

Key takeaways

Reported revenue rose modestly by 1% to approximately $590 million; constant currency growth was 3%, or 5% excluding the impact of the U.K. transition.
Adjusted EBITDA increased 15% on a reported basis and 5% in constant currency, driven by operational efficiency and cost discipline, supporting margin expansion.
U.S. lottery same-store sales were flat and below expectations, weighed down by challenging comparisons in large markets like California despite growth in Florida, Indiana, and Michigan.
Digital and iLottery platforms posted strong performance with global wagers up 30%, including a 36% increase in the U.S. and 27% in Italy, supported by new game launches and expanding distribution.
The company maintained a disciplined capital allocation approach, returning over $70 million to shareholders through dividends and buybacks, signaling confidence in cash flow stability amid mixed operational signals.

Corporacion America Airports S.A.

CAAP Q1 2026

Reported: 2026-05-14

Shares declined 1% following the quarter as investors digested solid passenger and revenue growth but showed caution amid persistent domestic traffic softness and operational disruptions, reflecting a mixed underlying performance without a clear upside catalyst.

Key takeaways

Passenger traffic increased 7% year over year, driven primarily by a 14% rise in international travel; domestic traffic was broadly stable but weighed down by temporary airline fleet constraints and a one-day nationwide strike in Argentina, as well as operational disruptions in Italy.
Revenues rose 19%, nearly triple the passenger traffic growth, supported by strong commercial momentum and currency appreciation, with Brazil, Armenia, and Argentina posting double-digit revenue growth.
Adjusted EBITDA expanded faster than passenger traffic, led by Argentina and Armenia, with margin improvement reflecting disciplined cost management.
Cargo revenue increased 16%, although cargo volumes showed mixed trends, with growth in Armenia and Argentina offset by declines elsewhere.
Despite geopolitical challenges affecting Armenia, the region showed resilience with a limited impact from Middle East conflict-related disruptions.

Costamare Bulkers Holdings Ltd

CMDB Q1 2026

Reported: 2026-05-14

Costamare Bulkers edged slightly higher by 1.8% as solid fleet renewal progress and derisking of legacy trades partially offset market volatility and geopolitical risks; however, gains remain modest reflecting cautious investor sentiment amid ongoing industry uncertainty.

Key takeaways

Adjusted net income reached $12.4 million ($0.51 per share) for Q1 2026, with net income of $9.9 million ($0.41 per share).
Majority of legacy trading portfolio transferred to Cargill, substantially derisking the balance sheet; full exit expected by year-end.
Fleet renewal advanced with sale of 2011 Capesize vessel (realizing ~$7 million capital gains), acquisition of a 2018 Ultramax, and delivery of newbuilding Kamsarmax vessels chartered on long-term profitable contracts.
Company is net cash positive by approximately $127 million, supported by $270 million in cash against $140 million debt, positioning for countercyclical growth.
Market conditions remain volatile with geopolitical disruption (Strait of Hormuz closure) impacting exports, though certain segments like Capesize and Panamax showed relative strength due to commodity demand and trade flows.

COMPASS Pathways plc

CMPS Q1 2026

Reported: 2026-05-14

The 17% stock rally signals strong investor approval of COMPASS Pathways’ progress toward NDA submission and potential accelerated launch of COMP360 for treatment-resistant depression (TRD), supported by positive Phase III data and regulatory milestones.

Key takeaways

Confirmed rolling NDA submission underway with final data expected in early Q3, supporting potential approval later this year.
Awarded the Commissioner's National Priority Voucher, enabling an ultra-accelerated FDA review timeline of 1-2 months post submission.
Positive Phase III trial results affirm COMP360’s rapid onset and sustained efficacy for TRD, offering a differentiated profile from existing treatments.
Commercial preparations progressing ahead of launch, including a growing salesforce and established psychedelic-specific CPT billing codes to facilitate reimbursement.
Early-stage PTSD program advancing with site activations, expanding the potential addressable market beyond TRD.

Constellation Software Inc.

CSU.TO Q1 2026

Reported: 2026-05-14

Constellation Software’s shares edged up 2.6% post-earnings, reflecting a modestly mixed quarter where margin pressures from recent acquisitions and non-core hardware weighed on profitability, while management’s outlook and deal pipeline showed no significant surprises.

Key takeaways

Q1 acquisitions were a drag on margins, reporting negative contributions initially with plans to improve over time.
Hardware margins declined from 46% to 43%, impacting overall margins by approximately 20 basis points.
Increased reliance on third-party professional services and maintenance added minor margin pressure.
Management noted stable private market valuations in their core acquisition focus area, with limited change post “SaaSpocalypse.”
Deal pipeline remains active though valuations remain high, with the company focusing on leveraging improved talent to navigate complex, larger deals.

CaliberCos Inc. Class A Common Stock

CWD Q1 2026

Reported: 2026-05-14

Caliber's shares were largely unchanged following Q1 results as the market digested a quarter broadly in line with internal plans but without clear catalysts to drive momentum. Modest advances in platform revenue and narrowing EBITDA losses offset caution on digital asset exposure and no change to full-year guidance.

Key takeaways

Platform revenue grew nearly 16% year-over-year, reflecting ongoing growth in core business lines.
Adjusted EBITDA loss narrowed by approximately $1 million, showing some cost discipline but still negative profitability at the platform level.
The company maintained its full-year 2026 guidance, signaling no near-term acceleration or revision despite evolving market conditions.
Strategic expansion into digital assets remains underway but faces headwinds, including a material decline in Link token price and a slower treasury accumulation pace.
Real estate tokenization projects and capital redeployment efforts indicate a focus on longer-term growth vectors rather than immediate earnings impact.

CXApp Inc. Class A Common Stock

CXAI Q1 2026

Reported: 2026-05-14

CXAI's shares edged up modestly by 2.0% following Q1 results, reflecting investor neutrality toward the company’s mixed execution and outlook. While bookings growth and new multi-year contracts point to expanding demand, the market appears unconvinced that current momentum translates into near-term margin expansion or meaningful guidance upside.

Key takeaways

Q1 bookings reached $1.4 million, including two large renewals and new client additions.
Secured over $5 million in new contract value across three multi-year financial services deals.
Continued heavy investment in R&D, with more than 70% of headcount in engineering and product.
Positioned at the intersection of workplace platforms and AI agents, targeting a significant future market.
Management emphasized strategy execution and product innovation but provided limited concrete margin or outlook detail.

DocGo Inc. Common Stock

DCGO Q1 2026

Reported: 2026-05-14

DocGo shares declined 0.8% after reporting moderate revenue growth but margin pressures and ongoing losses tempered investor enthusiasm. Despite increasing revenue guidance, investors appeared cautious given continued adjusted EBITDA losses and headwinds from labor costs and rising fuel prices.

Key takeaways

Q1 revenue totaled $75.6 million, driven by growth in virtual care and mobile phlebotomy segments.
SteadyMD revenue exceeded $9 million with 38% year-over-year visit growth; workforce expanded 45% to address demand.
Mobile phlebotomy revenue poised for up to 75% growth in 2026, with geographical expansion and technology integration planned.
Adjusted EBITDA loss was $10.2 million; labor inefficiencies at SteadyMD and higher fuel costs compressed gross margins by approximately 95 basis points combined.
Revenue guidance raised to $300–315 million for 2026, but adjusted EBITDA guidance maintained at a loss of $5–10 million, signaling cautious outlook on profitability.

Amdocs Limited

DOX Q2 2026

Reported: 2026-05-14

Amdocs shares declined modestly by 0.7% after reporting quarterly results that were broadly in line with expectations but failed to provide an uplifting catalyst. Investors likely reacted to cautious outlook commentary and a lack of strong upside drivers amid ongoing transformation efforts.

Key takeaways

Q2 revenue totaled $1.17 billion, with non-GAAP EPS of $1.78, both roughly at the midpoint of guidance.
Non-GAAP operating margin improved slightly by 20 basis points year-over-year, reflecting continued operational discipline alongside growth investments.
Backlog increased modestly to $4.28 billion, up 2.6% year-over-year and $30 million sequentially, indicating stable but unspectacular demand.
Initial commercial traction for the new aOS agentic operating system was reported, with several early customer agreements and early operational benefits noted at PLDT.
Management emphasized a multi-quarter strategic transformation toward an agentic, GenAI-native operating model but offered limited near-term financial clarity or amplified growth guidance.

Dr. Reddy's Laboratories Limited

DRREDDY.NS Q4 2026

Reported: 2026-05-14

Shares declined 1.1% following the earnings release as the company reported notable margin contraction and ongoing headwinds from lower lenalidomide sales, which overshadowed positives in the base business growth.

Key takeaways

Adjusted revenue declined 6% year-over-year for the quarter, primarily due to a 453 crore INR shelf-stock adjustment on lenalidomide and reduced sales of the product.
The underlying base business excluding lenalidomide showed double-digit year-over-year growth but could not offset declines in the key segment.
Gross margin contracted steeply by 760 basis points year-over-year to 48%, driven by lower lenalidomide sales and price erosion in unbranded generics.
SG&A expenses rose 11% year-over-year to 33% of adjusted revenues, reflecting higher investments in branded franchises and newly acquired consumer healthcare businesses.
Adjusted EBITDA fell 37% year-over-year to 1,554 crore INR for the quarter, with margin pressure reflecting both product-specific headwinds and increased operating costs.

Dynatrace, Inc.

DT Q4 2026

Reported: 2026-05-14

Dynatrace shares fell sharply (-11.4%) as investors reacted negatively to cautious fiscal 2027 guidance and signs of deceleration in growth momentum despite solid ARR scale. Margin commentary also hinted at pressure, limiting enthusiasm.

Key takeaways

Annual Recurring Revenue (ARR) surpassed $2 billion, with 16% year-over-year growth in Q4, marking the fourth consecutive quarter at this pace.
Logs consumption exceeded $100 million annually, growing over 100% year-over-year, reflecting strength in specific usage-based segments.
The company highlighted platform innovation including AI and cloud-native integrations, and recent acquisitions aimed at expanding capabilities in feature management and telemetry pipelines.
Management framed their platform’s architectural advantage amid growing hybrid AI-human observability demands, but investors appear unconvinced this will translate into near-term financial upside.
The fiscal 2027 outlook suggests tempered expectations around growth and margins, signaling margin compression risks and cautious investment in innovation.

Exodus Movement, Inc.

EXOD Q1 2026

Reported: 2026-05-14

Exodus shares declined 1.0% following the quarter as the company continued to show crypto-dependent revenue deceleration despite progress on diversifying with recent acquisitions; investors appear skeptical about the near-term impact of the new payments initiatives on profitability and growth.

Key takeaways

Trading volumes and digital asset prices fell in Q1, continuing a crypto-driven revenue downturn.
The Monavate and Baanx acquisitions were closed, marking a strategic shift toward recurring payment-related revenue streams separate from crypto volatility.
Exodus Pay launched nationwide (US, Canada, parts of Europe) with initial traction, adding a new payment product to the suite.
The company introduced XO Cash stablecoin aimed at AI agent payments, signaling innovation but with uncertain immediate financial impact.
Partnership announced with UFC for brand exposure and distribution, but financial benefits remain to be seen.

National Vision Holdings, Inc.

EYE Q1 2026

Reported: 2026-05-14

Shares dropped 15.4% following earnings as investors reacted to a cautious outlook and margin pressure despite reported revenue growth. The stock decline signals concerns that the ongoing strategic initiatives may not sustain expected momentum or profitability.

Key takeaways

Net revenue grew 6.6% to $544 million, with adjusted comparable store sales increasing 4.5%.
Adjusted operating margin expanded 210 basis points to 10.2%, reaching double digits aided by cost discipline and a shift toward more profitable customers.
Adjusted EPS increased to $0.45 per share from $0.34 a year ago.
Despite positive top-line drivers and product enhancements, the market’s negative reaction likely reflects doubts about the sustainability of growth, cautious guidance, and margin pressures amid macro uncertainties.
Management emphasized ongoing investments in higher-end product assortments and new technology categories, but these appear insufficient to assuage investor skepticism.

FLEX LNG Ltd.

FLNG Q1 2026

Reported: 2026-05-14

Shares fell 3.3% as investors reacted negatively to the cautious outlook highlighted by geopolitical risks and looming supply uncertainties, despite an increased full-year guidance in revenues and TCE rates. The market appears to discount ongoing medium-term headwinds and uncertainties around fleet newbuild deliveries.

Key takeaways

Updated full-year 2026 guidance increased revenues by ~10% to $345–370 million and TCE rates by 8% to $73,000–$78,000 per day, reflecting near-term market strength.
Adjusted EBITDA guidance raised by 11% to $255–280 million, supported by expanded contract backlog and stronger spot market fundamentals early in the year.
Fleet utilization was partially impacted by scheduled drydockings of three vessels, with associated higher voyage expenses increasing bunker and repositioning costs by $2 million versus Q4.
Management flagged heightened geopolitical risks (Iran conflict, Qatar LNG shutdown) and heavy newbuilding deliveries as reasons for medium-term uncertainty, maintaining a cautious "orange" market outlook.
Dividend held steady at $0.75 per share quarterly, with yield near 9.2%, reflecting commitment to shareholder returns amid prevailing risks but no upside surprise to alleviate concerns.

Fluent, Inc.

FLNT Q1 2026

Reported: 2026-05-14

Shares declined 3.0% after the print as investors appeared concerned by the continued revenue deceleration on a consolidated basis and margin pressures despite strong growth in the Commerce Media segment.

Key takeaways

Total revenue declined 19% year-over-year to $44.9 million, reflecting the divestiture of Call Solutions ($10.9 million in prior year); organic revenue declined 3% year-over-year.
Commerce Media Solutions drove 104% revenue growth to $25.9 million, now comprising 58% of total revenue versus 23% a year ago.
Gross profit fell 12% to $10 million, with Commerce Media gross profit up 78% but overall continuing business gross profit declined 7% year-over-year.
Adjusted EBITDA loss widened modestly to negative $3.6 million from negative $3.1 million a year ago, despite operating expense reductions excluding divestiture impacts.
Management emphasized long-term growth opportunities in Commerce Media, but near-term performance shows ongoing margin compression and overall revenue pressure.

Franco-Nevada Corporation

FNV Q1 2026

Reported: 2026-05-14

Franco-Nevada’s shares edged up modestly by 1.6% following a quarter marked by record revenues and income driven by strong commodity prices and strategic acquisitions, though the muted market reaction suggests investors remain cautious about sustainability of the momentum or near-term outlook.

Key takeaways

Revenue rose 77% year-over-year, with adjusted EBITDA up 84% and adjusted net income increasing 123%, supported by a 70% rise in average gold prices and significant gains in silver (+165%) and platinum (+128%).
Total gold equivalent ounces (GEOs) sold increased 8% to 136,353, including a 17% growth in precious metal GEOs to 117,980, driven by higher deliveries from key assets like Antamina.
The company completed four acquisitions during the quarter, expanding its royalty and stream portfolio with assets in stable mining jurisdictions, bolstering future optionality.
Energy revenue contributions are expected to improve in Q2 due to a recent sharp increase in oil prices to around $100/barrel, up from the $70 assumed in guidance, potentially lifting oil revenue by about 12%.
Sustainability initiatives advanced with an upgrade to MSCI ESG rating from AA to AAA, and ongoing environmental audits show no material deficiencies; however, investors may weigh this against potential operational risks and the reliance on commodity price strength.

FRP Holdings, Inc.

FRPH Q1 2026

Reported: 2026-05-14

FRP Holdings shares declined 2.0% after the quarter, reflecting investor caution around slow industrial leasing progress, lower multifamily occupancy in Washington, D.C., and continued near-term pressure on FFO despite stable NOI.

Key takeaways

Total NOI for Q1 was $8.9 million with FFO of $3.6 million, or $0.19 per share, highlighting ongoing margin and cash flow pressure.
Commercial and Industrial segment occupancy dropped significantly to 47.5% from 85% last year due to lease expirations and slower tenant decisions; NOI fell to $758,000 from $1.1 million.
Multifamily NOI was $4.1 million but came in below expectations as D.C. assets faced lower occupancy and elevated concessions amid local supply overhang; South Carolina remained relatively stable.
Mining and Royalties segment showed resilience with NOI up 15% year-over-year, driven by favorable volume and pricing.
Full-year 2026 NOI guidance remains around $37 million, but FFO expected to be pressured by lease-up delays, elevated platform costs, and higher interest expense, while G&A is set at $15-16 million to support scale-up efforts.

Gladstone Investment Corporation

GAIN Q4 2026

Reported: 2026-05-14

Shares fell 7.0% as investors reacted negatively to a cautious outlook amidst persistent macroeconomic headwinds and slower investment activity, overshadowing portfolio appreciation and the maintenance of distributions.

Key takeaways

Investment pace decelerated with $163 million deployed in four new buyout companies during fiscal 2026, down from $221 million the prior year, signaling reduced deal flow.
Net asset value (NAV) increased 34% year-over-year to $1.3 billion, largely driven by appreciation in existing investments rather than new acquisitions.
Maintained monthly distributions at $0.08 per share ($0.96 annually) plus supplemental distributions totaling $0.54 per share from capital gains, reflecting reliance on realized gains to support payouts.
Management emphasized ongoing caution due to macroeconomic uncertainty impacting demand and margins, highlighting efforts to optimize supply chains and cost structures across portfolio companies.
Portfolio remains diversified with 29 operating companies and a strong pipeline, but investors appear unsettled by the conservative tone and slowing investment momentum.

Gestamp Automocion, S.A.

GEST.MC Q1 2026

Reported: 2026-05-14

Shares fell 6.8% following the release as investors were disappointed by soft organic sales growth, ongoing volume declines in key markets such as China and Mercosur, and cautious comments on lower North American vehicle production, despite margin improvements.

Key takeaways

Reported revenues declined 5% year-over-year to EUR 2.83 billion, mainly due to unfavorable foreign exchange rates and a 0.3% drop in organic sales.
Global vehicle production struggled, down 3.4% year-over-year, with a sharp ~10% decline in China and a 2% decrease in North America and Western Europe, pressuring volume growth.
EBITDA margin expanded modestly to between 10.7% and 11.0%, driven by cost efficiencies and the Phoenix Plan, yet overall sales softness limits confidence in sustainable margin gains.
North American operations saw EBITDA margin improvement to 7.1% despite vehicle production in the region being below expectations, highlighting ongoing operational challenges.
Gescrap benefited from rising scrap prices in Q1, boosting revenues by about 12% quarter-on-quarter and improving EBIT margin to 6.4%, though the main automotive business faces headwinds.

Grocery Outlet Holding Corp.

GO Q1 2026

Reported: 2026-05-14

Shares fell 3.6% after Grocery Outlet’s Q1 report as investors were disappointed by the cautious outlook and ongoing margin pressure, despite modest traffic improvements and performance mostly tracking guidance.

Key takeaways

Q1 revenue rose 3.6% to $1.17 billion, with comparable store sales down 1%, better than the expected declines but still negative.
Traffic increased roughly 2%, improving through the quarter, but offset by lower units per transaction, signaling weak basket size.
Gross margin contracted to 29.6%, including a 50 basis point drag from store closures and promotional investments to drive traffic.
Adjusted EBITDA of $43.1 million was at the high end of guidance; adjusted EPS of $0.05 narrowly exceeded prior forecast by $0.01.
Management confirmed $20 million in promotional support investments planned for the year, reflecting ongoing margin headwinds and cautious near-term outlook.

Hyliion Holdings Corp.

HYLN Q1 2026

Reported: 2026-05-14

Hyliion’s 37.7% stock surge reflects strong investor approval of key operational milestones, notably the completion of UL Certification for its KARNO Power Module and significant revenue growth driven by expanding military engagements and a new data center partnership.

Key takeaways

Revenue surged to $2.8 million in Q1, a fourfold increase from the prior quarter, primarily fueled by military contracts.
Successfully completed UL Certification non-recurring tests, a critical gating milestone enabling early adopter deployments.
Signed a nonbinding letter of intent with VFG Holdings to deploy up to 250 KARNO cores (~50 MW) over five years targeting the data center market.
Demonstrated dynamic, seamless fuel switching (diesel, natural gas, hydrogen) during operation, validating true multi-fuel flexibility.
Remain on track to complete approximately 10 early adopter units this year with commercialization anticipated near year-end.

Inovio Pharmaceuticals, Inc.

INO Q1 2026

Reported: 2026-05-14

Shares declined 5.0% as investors reacted negatively to growing regulatory uncertainty and a cautious outlook for INO-3107’s accelerated approval, with no clear resolution on the FDA’s eligibility concerns or confirmatory trial protocol. The lack of concrete progress on these key regulatory milestones heightened execution risk and weighed on confidence.

Key takeaways

FDA completed mid-cycle review of the INO-3107 biologics license application (BLA) with no new significant issues, but an unresolved question remains regarding eligibility for accelerated approval.
An informal FDA meeting to discuss the eligibility concern, initially agreed upon, has yet to be scheduled, prolonging regulatory uncertainty.
Updated protocol for the required confirmatory trial has been submitted, but feedback is still pending, delaying clarity on future clinical development.
Management highlighted the product’s potential benefits based on prior Phase I/II data and differentiation versus competitors but provided no new data or definitive regulatory updates.
Operational cash burn is expected at approximately $18 million for Q2 2026, with cash runway into Q1 2027, indicating limited near-term financial flexibility amid regulatory delays.

Infinity Natural Resources, Inc.

INR Q1 2026

Reported: 2026-05-14

Shares of Infinity Natural Resources fell 6.3% following the earnings release, reflecting investor disappointment primarily with cautious commentary on near-term growth and an evident shift in capital allocation amid integration challenges from recent large acquisitions.

Key takeaways

Net production grew 88% year-over-year to 299 million cubic feet equivalent per day, bolstered by the Antero and Chase acquisitions.
The company increased rig and frac crew count with a record 10 wells drilled and 11 stimulated, highlighting operational scale-up efforts.
Integration of midstream assets is underway, but current utilization is low at less than 25% capacity, suggesting ramp-up risks and delayed financial contribution.
Management emphasized flexibility between volatile oil and natural gas drilling but pulled forward some oil-weighted completions to 2Q, leaving barrels largely unhedged, exposing results to commodity price risk.
Despite positive operating growth, investors appear concerned about a cautious outlook and margin pressure implied by the midstream underutilization and the complexity of assimilating new assets.

JBS N.V.

JBS Q1 2026

Reported: 2026-05-14

JBS shares dropped 8.4% following earnings as investors grappled with margin compression and significant losses in its U.S. beef segment, overshadowing top-line growth and operational cost controls.

Key takeaways

Net sales rose 11% to a record $21 billion, reflecting solid demand across several geographies.
EBITDA was approximately $1.1 billion, translating into a compressed margin of 5.2%, weighed down by the U.S. beef business.
The U.S. beef segment recorded a negative EBITDA of $230 million and a razor-thin 2.3% margin amid supply challenges and higher costs.
Free cash flow was negative $1.5 billion, worse than the prior year, driven by weaker earnings and increased capital expenditures.
Margin resilience in other segments like Seara (15.5% EBITDA margin) and Australia (7.1% margin) was insufficient to offset losses in North America.

Jushi Holdings Inc.

JUSHF Q1 2026

Reported: 2026-05-14

Jushi’s stock edged up modestly by 0.8% following a quarter marked by modest revenue growth and expanding margins but tempered by ongoing pricing pressure and increased promotions in retail.

Key takeaways

Revenue rose 4% year-over-year to $66.4 million, driven by retail expansion in Ohio and Virginia and wholesale growth in Massachusetts and Ohio.
Wholesale revenue increased 22.2%, supported by additional dispensary customers (+32) and new SKUs (+45% YoY).
Gross margin improved to 45% from 40.4% despite pricing pressure and promotional expenses in retail.
Adjusted EBITDA rose to $11.4 million (17.2% margin), benefiting from operational execution but excluding $2.8 million of nonrecurring credits from prior year.
Federal rescheduling of medical cannabis to Schedule III is a significant positive development with potential tax benefits going forward.

Kamada Ltd.

KMDA Q1 2026

Reported: 2026-05-14

Kamada’s shares fell 6.8% after earnings, reflecting investor disappointment with an acknowledged shipment delay that contributed to first-quarter revenue and adjusted EBITDA coming in only in line with expectations rather than showing growth momentum. Despite management's reiteration of full-year guidance and confidence in demand, the market appears skeptical of the outlook given early execution challenges.

Key takeaways

Reported Q1 revenues and adjusted EBITDA were in line with expectations, not exceeding them, impacted by a temporary shipment delay of a single order.
Management reaffirmed 2026 annual guidance of $200-$205 million in revenue and $50-$53 million in adjusted EBITDA, targeting double-digit growth solely through organic initiatives.
Underlying product demand, including increases in U.S. and international sales of key products like KEDRAB and GLASSIA, was highlighted but without clear evidence of acceleration in the quarter.
Expansion plans include launching additional biosimilars in Israel and growing plasma collection operations to improve vertical integration and cost control.
Ongoing clinical studies for CYTOGAM and increased market demand for VARIZIG support longer-term growth but have yet to translate into near-term financial upside.

Kornit Digital Ltd.

KRNT Q1 2026

Reported: 2026-05-14

Kornit Digital’s shares declined 1.6% after Q1 results as investors appeared cautious despite stable revenue and ongoing strategic execution, reflecting concerns over continued adjusted EBITDA losses and a lack of clear margin improvement.

Key takeaways

Reported revenues of approximately $48.5 million, near the high end of guidance.
Adjusted EBITDA loss remained at $2.8 million, extending operating losses despite continued positive operating cash flow.
Impressions grew approximately 12% year-over-year on a trailing 12-month basis, supported by both new and existing customers.
Annual Recurring Revenue (ARR) increased by $2.1 million, ending Q1 at about $27 million with expectations for acceleration in Q2 and beyond.
Company highlighted strong product pipeline and strategic acquisition of Print Factory to enhance software and automation offerings, aiming to drive future growth in scaled digital manufacturing.

LiqTech International, Inc.

LIQT Q1 2026

Reported: 2026-05-14

Shares declined 2.7% following the earnings release as investors reacted to ongoing deceleration in a key segment and cautious outlook despite some sequential margin improvement and growing order momentum in specific verticals.

Key takeaways

Revenue improved 32% sequentially from Q4 2025 but was held back by a non-repeating large water for energy delivery from the prior year’s quarter and timing of order conversions.
Gross margin expanded by approximately 1,290 basis points sequentially, reflecting operational improvements and portfolio transition.
Commercial pool and marine segments showed meaningful revenue growth year-over-year, with pool revenue increasing to $0.8 million from $0.3 million and marine doubling from $0.2 million to $0.8 million.
Management reiterated full-year revenue guidance of $23 million to $27 million, signaling no upward revision amid ongoing market uncertainties.
The business remains in transition toward more repeatable, service-supported platforms but continues to face challenges in visibility and order pacing, particularly in the water for energy segment.

Lightwave Logic, Inc.

LWLG Q1 2026

Reported: 2026-05-14

Shares rallied 14.3% as investors rewarded Lightwave Logic’s materially expanded market opportunity and traction with multiple large customers amid robust AI-driven demand surging the total addressable market (TAM) significantly beyond prior estimates.

Key takeaways

The 2028 combined AI and data center optical transceiver TAM jumped from $17 billion to approximately $47 billion, reflecting rapidly increasing bandwidth requirements driven by AI infrastructure growth.
The serviceable addressable market (SAM) for electro-optic polymer modulators widened to $2 billion–$4 billion, up from $1 billion–$2.5 billion last year.
Lightwave Logic now counts four major Stage 3/prototyping customers, all Fortune 500 or Global 500 firms, with additional Tier 1 customers expected to reach this milestone by Q3 2026.
Supply constraints in silicon photonic wafer foundries are slowing customer progression to manufacturing (Stage 4), impacting growth timing despite demand strength.
The company emphasized its differentiated electro-optic polymer platform’s potential to overcome limitations of existing indium phosphide and lithium niobate technologies.

Milestone Pharmaceuticals Inc.

MIST Q1 2026

Reported: 2026-05-14

Shares fell 9.5% following the quarter as investors reacted negatively to cautious early sales performance and a lack of clear near-term revenue acceleration despite a successful product launch and broad coverage progress.

Key takeaways

CARDAMYST launched quickly after FDA approval in December 2025 and became available nationwide by end of January 2026.
Approximately 600 total prescriptions were recorded through April, with steady month-over-month growth but still limited penetration.
Over 400 unique prescribers and about 560 unique patients indicated initial broad physician interest, yet script volume remains modest.
Early coverage includes 25% of commercially insured patients, anchored by Express Scripts formulary inclusion.
Management highlights positive patient and provider feedback but does not provide explicit revenue or profit guidance, suggesting cautious outlook.

Nexxen International Ltd.

NEXN Q1 2026

Reported: 2026-05-14

Nexxen’s shares surged 8.7% following Q1 results that beat expectations, driven by stronger than anticipated revenue growth in key segments and an upbeat outlook supported by AI-driven platform enhancements.

Key takeaways

Contribution ex-TAC programmatic and CTV revenues are trending ahead of forecasts, with CTV revenue up 12% year-over-year in Q1.
The company raised full-year guidance reflecting confidence in sustained growth momentum through expanding enterprise client base and enhanced go-to-market efforts.
AI capabilities continue to drive platform differentiation, delivering over 90% year-over-year efficiency gains in key operational workflows and reducing audience research time by more than 40%.
Investments in enterprise teams have resulted in onboarding more new enterprise clients in Q1 2026 than all of 2025, each with potential to generate $1 million+ in annual spend.
Strategic expansion includes strengthening CTV leadership through programmatic smart TV advertising and growing mobile in-app footprint to enhance resilience against AI-driven disruption.

NET Power Inc.

NPWR Q1 2026

Reported: 2026-05-14

Shares of NET Power surged 18.1% post-earnings, driven by investor optimism around the company’s clear pathway to delivering low-cost clean firm power at scale and its strategic positioning amid rising energy demand and security concerns.

Key takeaways

NET Power targets delivering clean firm power at under $100 per megawatt-hour, enabled by low-cost natural gas and enhanced oil recovery (EOR) in West Texas.
The company’s technology reduces lifecycle CO2 emissions by over 50% compared to unabated combined cycle natural gas plants, supporting environmental benefits.
Management emphasized speed, scale, and market acceptance of EOR as key factors for success in commercializing their solution.
Customer demand and alignment with the energy ecosystem remain critical before further capital commitments are made.
NET Power is advancing engineering, project financing, and commercial offtake discussions simultaneously to expedite project development.

The Navigator Company, S.A.

NVG.LS Q1 2026

Reported: 2026-05-14

Shares declined modestly by 0.4% as investors reacted to signs of operational disruption and margin pressure amid challenging external conditions. The combination of severe weather impacts, supply chain inflation, and a cautious outlook weighed on the quarter’s performance, offsetting gains from pricing initiatives and segment diversification.

Key takeaways

EBITDA fell 14% quarter-on-quarter to EUR 65 million, with margins retreating to 15.2%, pressured by lower prices in euros and production disruptions.
Extreme weather in Portugal caused temporary operational setbacks, reduced pulp and paper volumes, and pushed fossil fuel consumption and CO2 allowances costs higher.
Limited domestic wood supply forced increased imports, driving raw material costs upward alongside elevated logistics expenses due to altered transport routes.
Tissue and packaging segments now contribute nearly 40% of EBITDA, supporting portfolio resilience despite comprising only 31% of turnover.
Net debt decreased by EUR 28 million to a conservative 2.08x net debt-to-EBITDA ratio, with a well-staggered, sustainability-linked debt profile and ample liquidity of approximately EUR 570 million.

Nexus Industrial REIT

NXR-UN.TO Q1 2026

Reported: 2026-05-14

Shares declined 5.3% as investors reacted negatively to continued occupancy setbacks and a cautious outlook on near-term leasing, offsetting the benefit of a one-time lease termination fee and modest NOI growth. The market appears concerned that the recent vacancies will pressure results in coming quarters despite management’s assurances.

Key takeaways

Q1 net operating income rose 5.4% to $33.8 million; normalized FFO increased to $17.7 million.
Occupancy fell to 95% due to two unplanned vacancies: a 62,000 sq. ft. tenant early terminated for non-payment (with $1.2 million termination income) and an 88,000 sq. ft. tenant vacating a below-market lease.
Positive leasing performance included new leases covering 41,000 sq. ft. with average rent lifts of 32%, and renewal of 510,000 sq. ft. YTD at a 7% average increase (26% excluding one long-term reset).
Management expects short-term downtime from vacancies to offset termination income, maintaining unchanged guidance of mid-single-digit NOI growth and sub-100% AFFO payout ratio for 2026.
Secured an investment-grade BBB low rating and completed a $500 million inaugural bond offering to reduce financial risk and enhance capital flexibility.

PaySign, Inc.

PAYS Q1 2026

Reported: 2026-05-14

Shares plunged 12.9% as investors reacted negatively to the company’s cautious outlook and operational headwinds despite reported revenue growth. The disconnect likely stems from Q1 being described as “operationally constrained” and uncertainty around the impact of center closures in the plasma business.

Key takeaways

Revenue increased 50.8% year-over-year to $28 million, driven primarily by an 82% rise in the patient affordability segment to $15.7 million.
Operating margins expanded by 10.4 percentage points year-over-year, reflecting some operating leverage.
Patient affordability claim volume grew 49% versus Q1 2025, with $540 million in financial assistance provided to patients (up from $320 million).
Plasma donor revenue rose 25% to $11.7 million but faced headwinds from the closure of 19 low-performing centers and a net decline of 22 centers compared to end-2025.
Management highlighted that Q1 is typically a constrained period due to plan year renewals and formulary changes, suggesting potential near-term deceleration and pressure on growth visibility.

Power Corporation of Canada

POW.TO Q1 2026

Reported: 2026-05-14

Shares declined 1.1% despite reported 15% earnings growth, reflecting investor caution amid weaker contributions from alternative investments and rising corporate costs, tempering optimism from strong earnings-based business momentum.

Key takeaways

Adjusted net earnings rose 15% year-over-year to $905 million, with EPS at $1.43, the second highest since the 2019 reorganization.
Great-West and IGM each contributed 21% higher earnings, underpinned by sustained positive business momentum, strong net flows, and record AUM&A growth.
NAV per share increased 23% year-over-year to $84.54, driven primarily by robust growth across key operating companies and a 50% increase in cash balances.
Alternative investment platforms Sagard and Power Sustainable reported losses of $5 million and $13 million respectively, with Sagard impacted by lower private equity gains and Power Sustainable affected by lower asset management activity and infrastructure losses.
Corporate expenses were largely stable year-over-year but included higher dividends on preferred shares due to a recent $400 million issuance, contributing to elevated corporate operating losses.

Proximus PLC

PROX.BR Q1 2026

Reported: 2026-05-14

The +3.1% stock reaction reflects investor relief as domestic revenue growth, fiber subscriber gains, and stable Global direct margin signaled resilience amid mixed underlying trends. Key advances in fiber adoption and operational execution offset ongoing pressure in B2B hardware sales and a slight group EBITDA decline.

Key takeaways

Domestic service revenues were stable despite intense competition and a decline in sports content revenue; Domestic EBITDA grew 1.9% supported by lower OpEx.
Broadband fiber customers increased by 45,000 in Q1 to a total of 776,000, with fiber homes passed reaching nearly 2.7 million (42% population coverage).
The Global segment maintained a stable direct margin for the third consecutive quarter, though EBITDA remained down year-over-year, contributing to a 1.9% group EBITDA decline.
B2B revenues declined due to a drop in IT hardware sales (-EUR 22 million), driven by a tough comparable base and some temporary business slowdown, partly offset by stable IT services and only a mild decrease in fixed data revenue (-1%).
Free cash flow improved significantly to EUR 32 million (organic EUR 19 million), reflecting operating improvements and continued capex discipline despite heavy investments (EUR 261 million in Q1).

Paysafe Limited

PSFE Q1 2026

Reported: 2026-05-14

Paysafe’s stock rose 7.5% following Q1 results, reflecting better-than-expected growth driven by strong revenue and user metrics, particularly in Latin America and sports betting, alongside encouraging progress in AI-related commerce initiatives.

Key takeaways

Revenue grew 10% year-over-year with adjusted EBITDA up 4% and adjusted EPS increasing 21%.
Active consumer users reached 7.9 million, a 9% increase, with Latin America hitting a new record of 3.3 million active users.
Merchant-side e-commerce grew 17%, led by iGaming, which expanded 28%, while SMB business showed a modest 2% improvement.
Operating expenses rose 6%, mainly due to FX and investments in data infrastructure and marketing to support AI initiatives.
The company reaffirmed full-year growth outlook and highlighted improving net leverage to 5.2x, aiming for valuation support over the next two years.

Qnity Electronics, Inc.

Q Q1 2026

Reported: 2026-05-14

Qnity’s shares rose 5.7% following a quarter that saw accelerating demand driven by advanced nodes and packaging innovation, with both segments posting double-digit organic growth and notable margin expansion.

Key takeaways

Organic sales increased 17% year-over-year, marking the eighth consecutive quarter of profitable growth.
Semiconductor segment sales grew 12%, supported by scaling volumes at 3-nanometer nodes and initial activity at 2-nanometer nodes.
Interconnect Solutions delivered an exceptional 22% organic sales growth, fueled by share gains in Advanced Packaging and thermal management solutions.
Adjusted operating EBITDA rose 22%, reflecting strong operating leverage across both segments.
Capital investments continue with a new facility opened in Delaware and another planned in Taiwan to support advanced chip supply ramps.

Siemens Aktiengesellschaft

SIE.DE Q2 2026

Reported: 2026-05-14

Siemens shares rose 3.4% following Q2 results that demonstrated solid order momentum and robust growth in digital businesses, particularly data centers and software, which clearly outperformed expectations.

Key takeaways

Orders grew 18% year-over-year to EUR 24.1 billion, lifting backlog to a record EUR 124 billion with broad double-digit growth across all core businesses.
Digital Industries' software segment delivered a strong 14% revenue increase, while Smart Infrastructure’s electrification business surged 18%, driven by triple-digit order growth in the data center vertical.
Group revenue rose 6%, supported by growth across all regions, led by a 10% increase in the Americas and 21% revenue growth in India.
Industrial business profit margin remained robust at 15.4%, despite headwinds from U.S. tariffs in Mobility and currency pressures of 80 basis points expected to ease in H2.
Free cash flow improved sequentially to EUR 1.7 billion; the company confirmed full-year guidance with some segment-level adjustments, maintaining confidence in its strategic growth levers including AI and vertical integration.

Similarweb Ltd.

SMWB Q1 2026

Reported: 2026-05-14

Shares declined 1.6% following the earnings release, reflecting modest investor caution despite revenue growth at the top end of guidance and stabilization in retention metrics. The market appears wary of an outlook that while confident, offered limited upside surprises or clear inflection points.

Key takeaways

Revenue grew 10% year-over-year to $73.9 million, hitting the top end of guidance.
Non-GAAP operating profit also came in at the top end of guidance, underscoring disciplined cost management.
Normalized free cash flow was $6.6 million, marking 10 consecutive quarters of positive cash generation.
Net revenue retention stabilized at 98% overall, with stronger performance (103%) in accounts over $100,000, though without notable acceleration.
AI-related revenues expanded, supported by new contract wins and product launches including AI Studio, but market response suggests continued skepticism on near-term scaling impact.

StubHub Holdings, Inc.

STUB Q1 2026

Reported: 2026-05-14

StubHub's shares rose modestly by 2.7% following Q1 results that showed steady growth and margin expansion, reflecting investor cautious optimism amid solid execution without meaningful upside surprises.

Key takeaways

Gross merchandise sales (GMS) grew 7% year-over-year to $2.2 billion.
Adjusted EBITDA margin expanded to 16%, indicating improved profitability.
The company generated strong cash flow, enabling further deleveraging of the balance sheet.
Management reiterated full-year guidance for both GMS and adjusted EBITDA.
Progress made on product-led initiatives including AI-powered Distribution Manager and integration with primary ticketing platforms to broaden marketplace scale.

Takeda Pharmaceutical Company Limited

TAK Q4 2026

Reported: 2026-05-14

Shares in Takeda edged up modestly by 1.3%, reflecting a steady fiscal year 2025 performance that balanced ongoing LOE headwinds and pipeline progress, without clear market conviction on near-term growth catalysts.

Key takeaways

Core revenue was approximately JPY 4.5 trillion, partly pressured by loss of exclusivity in mature products.
Core operating profit reached around JPY 1.17 trillion, supported by robust cost management and efficiency measures.
Takeda delivered positive Phase III data for multiple late-stage assets, including oveporexton, rusfertide, and zasocitinib, setting the stage for potential regulatory approvals and launches in 2026.
The pipeline was further strengthened with Phase III starts for elritercept and mezagitamab, and strategic oncology partnerships expanded future growth opportunities.
Management emphasized disciplined commercial execution alongside innovation, signaling focus on upcoming launches amid a pivot to an evolved operating model to drive efficiency and sustainability.

Tencent Holdings Limited

TCEHY Q1 2026

Reported: 2026-05-14

Tencent's shares rose 5.7% on strong momentum from its AI initiatives and solid core business growth, signaling investor confidence in the company’s execution and AI-driven strategy.

Key takeaways

Total revenue reached RMB 196 billion, increasing 9% year-on-year and 11% adjusted for later Spring Festival timing.
Gross profit was RMB 111 billion, up 11% year-on-year, supported by growth across value-added services (VAS), marketing, and FinTech segments.
Non-IFRS operating profit excluding new AI products grew 17% year-on-year to RMB 84 billion, reflecting healthy profitability from core businesses.
The Hunyuan 3 Preview AI model has gained leading position in China on usage metrics, deployed across 131 Tencent internal products, and offers cost-efficient, comprehensive AI capabilities.
Management emphasized ongoing investment to scale larger AI models, leveraging improved data and reinforcement learning to enhance product and agent capabilities.

TORM plc

TRMD Q1 2026

Reported: 2026-05-14

Shares fell 5.6% as investors reacted negatively to a cautious outlook driven by significant market disruption and decelerating trade volumes amid the Strait of Hormuz closure, despite solid quarterly operational results.

Key takeaways

Q1 2026 TCE revenue reached USD 286 million, supported by strong freight rates and disciplined commercial execution.
EBITDA totaled USD 201 million with a net profit of USD 122 million, reflecting operational leverage in a challenging environment.
Full year guidance was raised to USD 1.15 billion–1.45 billion, signaling confidence but tempered by ongoing geopolitical risks and supply disruptions.
The closure of the Strait of Hormuz led to a 16% drop in global clean petroleum product trade and a similar decline in crude volumes, constraining freight volumes despite elevated rates.
Fleet renewal continued with 95 vessels at quarter-end and plans to increase to 103, maintaining flexibility amid market uncertainty.

Tower Semiconductor Ltd.

TSEM Q1 2026

Reported: 2026-05-14

The stock surged 27.1% post-earnings, driven by significant demand visibility from long-term, contracted silicon photonics revenue and impressive execution on capacity expansion, markedly exceeding market expectations.

Key takeaways

Q1 2026 revenue grew 15% year-over-year to $414 million, with net profit up 62% to $65 million, lifting net margin to 16% from 11% a year ago.
Management guided Q2 revenue to a record $455 million (+22% YoY, +10% QoQ), reinforcing expectations for sustained quarterly growth.
Long-term contractual commitments in silicon photonics now stand at $1.3 billion for 2027, backed by $290 million in prepayments, highlighting strong customer confidence and visibility.
Significant progress in 300-millimeter wafer capacity with full ownership of Fab 7 enabling scalable expansion and profitable operations at current volumes.
Breakthroughs in next-generation silicon photonics technology, including new high-speed optical modulators and partnerships advancing high-volume manufacturing readiness for emerging AI data center demands.

USA Rare Earth Inc

USAR Q1 2026

Reported: 2026-05-14

USA Rare Earth’s shares declined modestly by 0.5% following a quarter marked by significant strategic transactions but without immediate operational or financial upside to move investor sentiment. The market reaction suggests cautious reception despite ongoing progress on integration and capacity expansion.

Key takeaways

Announced three transformative transactions: acquisition of Serra Verde Group, strategic investment in Carester, and consolidation of the Round Top Project, aimed at creating a fully integrated mine-to-magnet platform spanning three continents.
Serra Verde acquisition secures Pela Ema mine, the only scaled producer outside Asia of key magnetic rare earths, with a 15-year offtake including price floors for critical elements like dysprosium and terbium.
Raised $1.5 billion via PIPE financing and nearing $1.6 billion Department of Commerce funding, supporting accelerated build-out and derisking of production plans.
Operational progress includes commissioning of Phase 1a at Stillwater magnet plant, with customer-ready NdFeB magnet production expected to start in Q2 2026 and sales planned for H2 2026.
Despite structural progress and growing customer engagement across sectors, the quarter lacks concrete revenue or profit milestones to justify a stronger market reaction.

Usio, Inc.

USIO Q1 2026

Reported: 2026-05-14

Usio's shares surged 21.1% post-earnings, driven by record revenue growth, significant gains in payment volumes, and positive adjusted EBITDA that outpaced expectations.

Key takeaways

Revenue increased 16% year-over-year, hitting the highest quarterly revenue in company history.
Total payments dollars processed rose 28%, with transactions up 22%, underscoring strong underlying volume growth.
Card revenue led with a 23% increase, driven by PayFac representing 78% of card revenues and successful new enterprise account implementations.
Margins declined due to reduced interest income (which carries 100% gross margin) and revenue mix effects; management expects eventual margin improvement.
Operating cash flow remained positive at over $7.7 million, with overhead expenses modestly reduced sequentially, reflecting operating leverage.

Vishay Intertechnology, Inc.

VSH Q1 2026

Reported: 2026-05-14

Vishay's shares surged 14.5% following a quarter that delivered revenue above guidance, broad-based volume growth, expanding backlog, and robust book-to-bill ratios—signaling strong demand and successful execution on its Vishay 3.0 strategy.

Key takeaways

Q1 revenue reached $839 million, beating the guidance range of $800 million to $830 million and increasing 4.8% sequentially and 17.3% year-over-year.
Volume grew 5.8% with gains in both semiconductors and passives, driven by replenishment, market share gains, and accelerating industrial demand.
Book-to-bill at quarter end was 1.34 (up from 1.2), with semiconductor book-to-bill at 1.47 and passives at 1.23, supporting a 21% backlog increase to $1.6 billion (5.7 months).
Automotive revenue rose 2.7% sequentially supported by EV program ramps and strong OEM demand in Americas and Europe.
Industrial power revenue increased 6.5%, marking the fifth consecutive quarter of sequential growth, fueled by AI infrastructure, smart grid, renewable energy, and power management projects.

Wesdome Gold Mines Ltd.

WDO.TO Q1 2026

Reported: 2026-05-14

Wesdome’s Q1 results beat expectations, driving a 3.1% positive stock reaction, supported by record revenue, strong production, and robust free cash flow that enabled continued share repurchases.

Key takeaways

Revenue reached a record $300 million, supported by sustained solid production and strong gold prices.
Net income hit $119 million, or $0.79 per share, marking a continuation of sequential financial growth.
EBITDA totaled $212 million, reflecting efficient operational execution.
Operating cash flow was $162 million, with free cash flow at a record $126 million, representing 42% of revenue.
The company repurchased nearly $50 million in shares, with a second tranche approved, signaling confidence in the business outlook.

Wix.com Ltd.

WIX Q1 2026

Reported: 2026-05-14

Shares dropped 27.1% following earnings as investors were evidently disappointed by a cautious outlook and the ramp-up in marketing expenses, particularly related to the BASE44 acquisition, which pressured near-term profitability.

Key takeaways

Marketing spend increased significantly in Q1, driven by efforts to capture BASE44’s demand and integrate the acquisition.
BASE44 showed solid growth, hitting $150 million ARR in mid-May, up from $100 million ARR in early March, but marketing ROI (TROI) remained stable rather than improving.
New user cohorts generated nearly $52 million in bookings in the first three months, a 46% increase over Q1 2025 cohorts, bolstered by improved conversion and monetization linked to the Harmony platform.
Management emphasized proprietary AI model deployment and AI integration as strategic advantages, but there was no clear evidence this translated into near-term financial upside.
Despite healthy cohort trends, the combination of increased spending and cautious forward commentary likely weighed on investor sentiment.

Worksport Ltd.

WKSP Q1 2026

Reported: 2026-05-14

Shares fell 7.8% as investors reacted to cautious outlook commentary and ongoing margin pressure despite year-over-year revenue growth, signaling concerns over near-term profitability and conversion risks.

Key takeaways

Revenue grew approximately 48% year-over-year to $3.3 million, showing top-line expansion albeit from a low base.
Gross profit more than doubled to $854,000, but gross margin was a modest 26%, indicating margin benefits remain limited.
Management emphasized Q1 as a launch-readiness quarter with significant investments in inventory and distribution, delaying margin expansion and profitability.
The company highlighted continued operational cash burn related to scaling efforts, underscoring liquidity and funding risks.
Although the product portfolio and dealer network were expanded, investors appear skeptical on the pace of sales channel conversion and margin efficiency improvements expected in H2.

Wrap Technologies, Inc.

WRAP Q1 2026

Reported: 2026-05-14

The stock rose modestly by 0.7% after reporting first quarter revenue growth driven by increased product sales, while gross margin compression and a cautious outlook on margin improvement kept gains in check.

Key takeaways

Total revenue increased 45% year-over-year to $1.1 million, lifted by a 186% increase in product sales to $0.9 million.
Technology-enabled services revenue declined to $0.2 million from $0.5 million a year ago, due to the wind down of advisory services offset by subscription growth.
Gross margin contracted to 62% from 78% last year, reflecting a higher mix of lower-margin hardware sales.
Operating expenses rose to $5.5 million from $4.5 million, driven by higher share-based compensation and investments in sales expansion.
Cash used in operations improved 59% to $1.2 million, indicating tighter cost control amid ongoing growth investments.

Westwater Resources, Inc.

WWR Q1 2026

Reported: 2026-05-14

Shares of Westwater Resources declined 1.4% post-earnings as investors digested ongoing challenges in customer agreements and permitting timelines, reflecting cautious sentiment despite progress on operational milestones.

Key takeaways

Kellyton qualification line produced over 1 metric ton of CSPG samples for customer testing, supporting ongoing qualification efforts.
SK terminated its product procurement agreement, signaling volatility and evolving dynamics in customer demand within the battery supply chain.
Coosa graphite deposit advanced federally with FAST 41 designation, intended to improve permitting coordination, though full permitting remains on a 12–24 month horizon.
Phase 1 capital estimate at Kellyton remains steady at approximately $245 million, with $19 million in untouched contingency and $129.6 million invested to date.
Company ended Q1 with $41.5 million cash and $71 million available on the ATM program, pursuing multiple financing options including government funding to complete Phase 1.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.